top of page

Clinical Evidence for Astaxanthin as an Ocular Carotenoid

  • 1 hour ago
  • 2 min read

At the 2026 International Symposium on Carotenoids, scientists, academics, and industry leaders specializing in carotenoids gathered in Palma de Mallorca to share their research.

 

AstaReal and Fuji Chemical Industries joined as proud sponsors of this prestigious event that is held once every three years and this time, we showcased natural astaxanthin on visual health together with Fuji's new corporate branding as part of our 80th anniversary.


AstaReal Fuji Delegates at the 20th International Symposium on Carotenoids, Palma, Spain
Delegates: Fuji Chemical Industries (Japan & India), AstaReal Inc., (USA) AstaReal Pte Ltd (Singapore), Universiti Sains Malaysia.

Karen Hecht Ph.D., Vice President of AstaReal Inc., showcased clinical and biochemical evidence supporting the efficacy of astaxanthin, a xanthophyll carotenoid derived from Haematococcus pluvialis, as a therapeutic agent for ocular health in adults and children. It highlighted astaxanthin's superior antioxidant properties, bioavailability, and clinical utility in mitigating modern visual impairments like Computer Vision Syndrome (CVS) also known as Digital Eye Syndrome (DES) and more.


Introducing Natural Astaxanthin Clinical Research for Eye Health in the Digital Age

Poster presentation on Natural Astaxanthin as an Ocular Carotenoid

A Snapshot of Scientific Findings and Clinical Data


  • The Prevalence of Digital Eye Syndrome and a Unifying Concern

  • How Ocular Nutrition Influences Long-Term Visual Health

  • Visual Function and Accommodation

  • Ocular Surface and Pathologies

  • Mechanism and Bioavailability

  • Ocular Microcirculation


Dr Hecht said that average U.S. standard dietary intake provides insufficient astaxanthin (averaging 11 mg annually). Therefore, targeted supplementation of 4–12 mg/day is necessary to achieve clinically significant improvements in accommodation, microcirculation, and ocular surface health.


Futhermore, AstaReal is proud to release our Vision eBook 2026 entitled, ''Astaxanthin and the Evolution of Vision Care in a Screen-Centric World''. It contains details of all the clinical research on astaxanthin in Digital Eye Syndrome (DES).


What is this good for?

  • Research

  • Formulation Development

  • Scientific Communications

  • Regulatory Affairs

  • Public Health Policy Related


Click on the image to leave your contact and gain access to the Vision Care ebook.



About the International Symposium on Carotenoids


The 20th International Symposium on Carotenoids (ISC Palma 2026), which took place in Palma, Spain, from June 14–19, 2026, serves as the premier global gathering for scientists, researchers, and industry professionals dedicated to the study of carotenoids (the natural pigments responsible for the bright red, yellow, and orange colors in plants and animals).

 

The primary purpose of the 2026 symposium was to provide a highly collaborative, interdisciplinary platform to advance Carotenoid Science and Technology and organised under the International Carotenoid Society

 

2026 symposium also marked the 60th anniversary of the conference series, continuing its legacy of offering authoritative, evidence-based insights into these vital natural compounds.


Comments


CONTACT US

1 Kim Seng Promenade

Great World City East Office Tower, 

#11-06, Singapore 237994

+65 6222 1778

  • linkedin
  • facebook
  • Black Instagram Icon

Your details were sent successfully!

Subscribe Form

Thanks for subscribing!

©2026 by AstaReal PTE LTD

2023 new HSIAS logo.jpg
bottom of page